ReviewInternational journal of hematology2011

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.

Sarah K Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.